Table 1 CF patients and clinical characteristics.

From: Cell free DNA from respiratory pathogens is detectable in the blood plasma of Cystic Fibrosis patients

Patient IDAgeSexCFTR genotypeBody Mass Index (BMI, kg/m²)Forced Expiratory Volume (FEV1, L, % of predicted)Forced Vital Capacity (FVC, L, % of predicted)FEV1/FVC ratio
CF119FemaleF508del/F508del19.522.01 (60%)3.15 (83%)0.64
CF239MaleF508del/621 + G > T24.93.58 (80%)4.54 (96%)0.66
CF332FemaleF508del/F508del26.592.59 (80%)3.58 (92%)0.72
CF430FemaleF508del/G551D23.122.72 (82%)3.98 (102%)0.68
CF528FemaleF508del/2789 + 5 G > A18.281.22 (38%)2.23 (60%)0.55
CF626MaleF508del/W1282X20.72.99 (72%)4.04 (83)0.74
CF728MaleF508del/G542X21.742.13 (43%)3.53 (60%)0.6
CF855MaleF508del/1717–1 G21.750.83 (23%)1.91 (40%)0.43
CF957MaleF508del/G551D23.261.51 (42%)3.09 (66%)0.49
CF1024FemaleF508del/F508del19.681.84 (53%)1.91 (47%)0.96
CF1129FemaleF508del/F508del18.421.15 (42%)2.0 (63%)0.58
CF1222FemaleW679X/unknown22.221.5 (52%)2.4 (73%)0.63
CF1362FemaleF508del/D1152H23.641.5 (56%)2.08 (59%)0.72
CF1461MaleF508del/S945L26.422.76 (37%)3.59 (79%)0.77
CF1521FemaleF508del/F508del19.441.26 (37%)1.88 (48%)0.72
CF1635FemaleF508del/R1066C20.070.92 (30%)1.97 (53%)0.47
CF1733FemaleF508del/F508del20.171.04 (36%)1.73 (51%)0.6
CF1830MaleF508del/R553X17.631.08 (23%)2.26 (40%)0.48
CF1925MaleF508del/621 + 1 G > T23.222.0 (50%)2.67 (57%)0.75
CF2031FemaleF508del/R117H-5T28.943.73 (111%)4.64 (117%)0.8
CF2144FemaleF508del/F508del21.91.96 (71%)3.39 (100%)0.58